|

mFOLFIRINOX regimen Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Revolution Medicines, Inc.1

Indications

  • PDAC1
  • CRC1
  • Gastrointestinal Cancer1
  • Pancreatic Ductal Adenocarcinoma1
  • Metastatic Pancreatic Ductal Adenocarcinoma1

Chandler, Arizona1 trial

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Ironwood Cancer and Research Centers

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.